Key facts
- Notable investors include Transpose Platform Management, Mayo Clinic Platform, Rock Yard Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Bluevia Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Bluevia Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bluevia Health
Developer of a healthcare analytics platform designed to forecast perioperative patient deterioration and support clinical decision-making. The company's platform uses multimodal perioperative data inputs, applies predictive models to identify high-risk patients before and after surgery, provides risk stratification and deterioration alerts, and integrates into clinical workflows, enabling hospitals and surgical care teams to reduce preventable complications and improve patient outcomes.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 4
- Website
- blueviahealth.com/
- Ownership
- Privately Held (backing)
Bluevia Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bluevia Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bluevia Health in its N-PORT filings yet. We sweep new filings monthly.